Arlington, MA, United States of America

Jack T Rogers

USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Jamaica Plain, MA (US) (2001 - 2005)
  • Arlington, MA (US) (2006 - 2018)

Company Filing History:


Years Active: 2001-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jack T Rogers: Innovator in Neurodegenerative Disorder Treatments

Introduction

Jack T Rogers is a notable inventor based in Arlington, MA (US), recognized for his contributions to the field of neurodegenerative disorders. With a total of 4 patents, he has made significant strides in developing treatments for conditions such as Down syndrome and Alzheimer's disease.

Latest Patents

Among his latest patents, one focuses on "Amyloid precursor protein mRNA blockers for treating Down syndrome and Alzheimer's disease." This patent discloses methods for treating neurodegenerative disorders by administering agents that inhibit or reduce the translation of amyloid precursor protein. The invention also includes methods for decreasing amyloid-beta production in a subject's brain and restoring iron homeostasis. Another significant patent involves "Peptides derived from the human amyloid precursor protein," which are designed to protect cells from iron-catalyzed oxidative damage.

Career Highlights

Throughout his career, Jack T Rogers has worked with esteemed institutions such as Brigham and Women's Hospital, Inc. and The General Hospital Corporation. His work has been pivotal in advancing research and treatment options for neurodegenerative diseases.

Collaborations

Jack has collaborated with notable colleagues, including Xudong Huang and James Spoonamore, contributing to the development of innovative solutions in his field.

Conclusion

Jack T Rogers stands out as a dedicated inventor whose work has the potential to significantly impact the treatment of neurodegenerative disorders. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…